European Pillar of Social Rights – a reality for European families

European Pillar of Social Rights a reality for Europe’s families: mind the gap The European Commission put forward a first,preliminary outline of what should become the European Pillar of Social Rights,in March 2016. Wide public consultation are taking place throughout 2016 to allow Member States’ Authorities, social partners and European citizens to give feedback on…

Read More

Conference:Counterfactual Methods for Policy Impact Evaluation (COMPIE 2016)

Events 20/10 – 21/10/2016  Conference – Counterfactual Methods for Policy Impact Evaluation ( COMPIE 2016) The European Commission, in collaboration with Università Cattolica del Sacro Cuore in Milan, is organising the Counterfactual Methods for Policy Impact Evaluation 2016 (COMPIE 2016) conference on 20 and 21 October 2016. It brings together policy makers and researchers to…

Read More
European Institute of womens health, Eurohealth health logo

Europe listens to the citizens’ voice

PRESS RELEASE Europe listens to the citizens’ voice Saturday 24th September 2016 On Saturday in eight countries across Europe hundreds of citizens met to discuss and vote simultaneously on what European citizens think about epidemic and pandemic preparedness and response. The consultation meetings are part of a European Research project called ASSET which focuses on…

Read More

Direct cost of alcohol abuse is over €155 billion

Alcohol -3rd highest risk to causing disease and death in EU. Tackling alcohol related harm The direct costs through healthcare, crime, policing, accidents and productivity losses were €155 billion in 2010. EU strategy to support Member States in reducing alcohol related harm identifies common priorities, including the need to develop common evidence base and monitoring,…

Read More

Many to benefit from £2-a-day anti-clotting drug

Many to benefit from £2-a-day anti-clotting drug preventing heart attacks and strokes The draft guidance for ticagrelor for reducing the risk of cardiovascular events in people who have had a heart attack NICE has published draft guidance recommending anti-clotting drug ticagrelor 60 mg (Brilique, Astrazeneca) with aspirin for people who have had a heart attack.…

Read More

Osteoarthritis caused by growing old?

Osteoarthritis can be caused by: Researchers have uncovered evidence that cellular senescence (growing old)- when cells stop dividing – is a cause of osteoarthritis, and they suggest by targeting these cells a promising way to prevent or treat the condition may be found. Osteoarthritis (OA), known to be as degenerative joint disease, is a condition…

Read More

Recommendation of secukinumab for patients with ankylosing spondylitis In draft guidance NICE,England and Wales,recommends innovative new drug secukinumab (Cosentyx, Novartis) for treating ankylosing spondylitis. Ankylosing spondylitis is a type of arthritis that mainly affects the back. Secukinumab was licensed for use in UK in May, is first in a new class of drug to treat…

Read More